HALO · Halozyme Therapeutics, Inc. · Documents
$123.20
-1.18 (-0.94%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$14.12B
Shares
113.50M
Volume · Oct 21
547.75K
Avg daily vol (3M)
2.24M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| Investor Event Transcript | — | 2025-01-08 | 2025-03-31 | |
| 8-K | — | 2024-10-31 | — | |
| 10-Q | — | 2024-10-31 | 2024-09-30 | |
| 8-K | — | 2024-08-06 | — | |
| 10-Q | — | 2024-08-06 | 2024-06-30 | |
| 10-Q | — | 2024-05-07 | 2024-03-31 | |
| 8-K | — | 2024-05-07 | — | |
| 8-K | — | 2024-04-26 | 2024-04-25 | |
| ARS | — | 2024-03-15 | 2023-12-31 | |
| DEF 14A | — | 2024-03-15 | 2023-12-31 | |
| DEFA14A | — | 2024-03-15 | — | |
| PRE 14A | — | 2024-03-04 | 2023-12-31 | |
| 10-K | — | 2024-02-20 | 2023-12-31 | |
| 8-K | — | 2024-02-20 | — | |
| 8-K | — | 2024-01-17 | — | |
| 10-Q | — | 2023-11-06 | 2023-09-30 | |
| 8-K | — | 2023-11-06 | — | |
| 8-K | — | 2023-09-07 | 2023-09-06 | |
| 10-Q | — | 2023-08-08 | 2023-06-30 | |
| 8-K | — | 2023-08-08 | — | |
| 10-Q | — | 2023-05-09 | 2023-03-31 | |
| 8-K | — | 2023-05-09 | — | |
| 8-K | — | 2023-05-08 | 2023-05-05 | |
| ARS | — | 2023-03-24 | 2022-12-31 | |
| DEF 14A | — | 2023-03-24 | — | |
| DEFA14A | — | 2023-03-24 | — | |
| 8-K | — | 2023-03-16 | 2023-03-15 | |
| 8-K | — | 2023-03-13 | 2023-03-10 | |
| 8-K | — | 2023-02-23 | 2023-02-22 | |
| 8-K | — | 2023-02-21 | — | |
| 10-K | — | 2023-02-21 | 2022-12-31 | |
| 8-K | — | 2023-02-06 | 2023-02-03 | |
| 8-K | — | 2023-01-10 | — | |
| 10-Q | — | 2022-11-08 | 2022-09-30 | |
| 8-K | — | 2022-11-08 | — | |
| 8-K | — | 2022-08-19 | 2022-08-18 | |
| 8-K | — | 2022-08-18 | 2022-08-15 | |
| 8-K | — | 2022-08-16 | 2022-08-15 | |
| 8-K | — | 2022-08-15 | — | |
| 8-K/A | — | 2022-08-09 | 2022-05-24 | |
| 10-Q | — | 2022-08-09 | 2022-06-30 | |
| 8-K | — | 2022-08-09 | — | |
| 8-K | — | 2022-05-24 | — | |
| SC TO-T/A | — | 2022-05-24 | — | |
| SC TO-T/A | — | 2022-05-12 | — | |
| 8-K | — | 2022-05-10 | — | |
| 10-Q | — | 2022-05-10 | 2022-03-31 | |
| 8-K | — | 2022-05-06 | 2022-05-05 | |
| SC TO-T/A | — | 2022-05-02 | — | |
| SC TO-T | — | 2022-04-26 | — |
Showing 51–100 of 150 filings
Key facts
CIK
1159036
CUSIP
40637H109
13F (30d)
121 filings
118 filers
Visit website
Investor relations